Cellebrite DI (CLBT) Change in Receivables (2020 - 2025)

Cellebrite DI's Change in Receivables history runs 6 years deep, the most recent figure standing at $4.7 million for Q4 2025.

• On a quarterly basis, Change in Receivables fell 54.65% year-over-year to $4.7 million in Q4 2025; TTM through Dec 2025 was -$15.8 million, a 170.73% decrease from a year earlier, with the FY2025 full-year figure at $15.8 million, up 170.73% from the prior year.
• Change in Receivables improved to $4.7 million in Q4 2025 per CLBT's latest filing, from -$11.2 million in the prior quarter.
• Across five years, Change in Receivables topped out at $15.3 million in Q1 2024 and bottomed at -$24.4 million in Q3 2021.
• The 5-year median for Change in Receivables is $3.2 million (2025), against an average of -$1.7 million.
• Across the five-year window, Change in Receivables jumped 255.26% in 2021 and plunged 208.8% in 2024, its largest moves.
• Year by year, Change in Receivables stood at $8.7 million in 2021, then rose by 29.37% to $11.2 million in 2022, then tumbled by 162.86% to -$7.1 million in 2023, then surged by 245.22% to $10.3 million in 2024, then tumbled by 54.65% to $4.7 million in 2025.
• Per Business Quant, the three latest CLBT Change in Receivables figures stand at $4.7 million (Q4 2025), -$11.2 million (Q3 2025), and -$10.9 million (Q2 2025).